CO6300794A2 - Mamiferos transgenicos que producen proteina exogena en la leche - Google Patents
Mamiferos transgenicos que producen proteina exogena en la lecheInfo
- Publication number
- CO6300794A2 CO6300794A2 CO10002774A CO10002774A CO6300794A2 CO 6300794 A2 CO6300794 A2 CO 6300794A2 CO 10002774 A CO10002774 A CO 10002774A CO 10002774 A CO10002774 A CO 10002774A CO 6300794 A2 CO6300794 A2 CO 6300794A2
- Authority
- CO
- Colombia
- Prior art keywords
- human insulin
- mammals
- transgenic
- milk
- recombinant human
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 8
- 235000013336 milk Nutrition 0.000 title abstract 3
- 239000008267 milk Substances 0.000 title abstract 3
- 210000004080 milk Anatomy 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 7
- 230000009261 transgenic effect Effects 0.000 abstract 6
- 101000976075 Homo sapiens Insulin Proteins 0.000 abstract 5
- 241000283690 Bos taurus Species 0.000 abstract 3
- 239000002243 precursor Substances 0.000 abstract 3
- 235000018102 proteins Nutrition 0.000 abstract 2
- 231100000331 toxic Toxicity 0.000 abstract 2
- 230000002588 toxic effect Effects 0.000 abstract 2
- 102000011632 Caseins Human genes 0.000 abstract 1
- 108010076119 Caseins Proteins 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 229960000074 biopharmaceutical Drugs 0.000 abstract 1
- 210000002257 embryonic structure Anatomy 0.000 abstract 1
- 239000013613 expression plasmid Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000001605 fetal effect Effects 0.000 abstract 1
- 210000002950 fibroblast Anatomy 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 210000005075 mammary gland Anatomy 0.000 abstract 1
- 210000000287 oocyte Anatomy 0.000 abstract 1
- 210000001082 somatic cell Anatomy 0.000 abstract 1
- 235000021247 β-casein Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
- C12N15/877—Techniques for producing new mammalian cloned embryos
- C12N15/8771—Bovine embryos
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/101—Bovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Environmental Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se relaciona con mamíferos trasgénicos no humanos que son útiles en la producción de una proteína de interés que puede ser tóxica para los mamíferos. El mamífero se caracteriza por el hecho de que es transgénico para la producción en su leche de una forma inactiva de la proteína de interés, preferiblemente insulina humana recombinante. No es posible producir insulina humana recombinante en mamíferos transgénicos en razón a que esta molécula tiene un cierto grado de actividad biológica en Los mamíferos y podría ser tóxica para el mamífero. Así, la invención involucra donar una construcción genética que comprende una secuencia que codifica un precursor modificado de insulina humana bajo el control de un promotor de caseína beta en un vector de expresión. Esto también involucra transfectar el plásmido de expresión en las células somáticas bovinas fetales, tal como los fibroblastos, y enuclear los oocitos bovinos mediante transferencia nuclear para generar embriones transgénicos. La invención da origen a un bovino transgénico que será capaz de producir un precursor modificado de insulina humana en sus glándulas mamarias. Posteriormente, la leche de estos mamíferos transgénicos se puede recolectar, el precursor modificado de insulina humana se puede convertir in vitro en insulina humana recombinante, y la insulina humana recombinante se puede purificar para homogenizarla como un producto biofarmacéutico puro.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92909807P | 2007-06-13 | 2007-06-13 | |
| US92909507P | 2007-06-13 | 2007-06-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6300794A2 true CO6300794A2 (es) | 2011-07-21 |
Family
ID=40156522
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10002774A CO6300794A2 (es) | 2007-06-13 | 2010-01-13 | Mamiferos transgenicos que producen proteina exogena en la leche |
| CO10002779A CO6300796A2 (es) | 2007-06-13 | 2010-01-13 | Proceso para la produccion de proteina exogena en la leche de mamifero transgenico |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO10002779A CO6300796A2 (es) | 2007-06-13 | 2010-01-13 | Proceso para la produccion de proteina exogena en la leche de mamifero transgenico |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20090228999A1 (es) |
| EP (2) | EP2061895A1 (es) |
| JP (2) | JP2010528677A (es) |
| CN (2) | CN101755054A (es) |
| AU (2) | AU2008266993A1 (es) |
| BR (1) | BRPI0811390A2 (es) |
| CA (2) | CA2690564A1 (es) |
| CO (2) | CO6300794A2 (es) |
| MX (2) | MX2009013421A (es) |
| RU (2) | RU2010100910A (es) |
| WO (2) | WO2008156668A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2489441C1 (ru) * | 2009-07-09 | 2013-08-10 | Биокон Лимитед | Препаративный хроматографический способ на основе нелинейного градиента и продукты, очищенные этим способом |
| CN102816819B (zh) * | 2012-08-13 | 2014-10-29 | 山东阿华生物药业有限公司 | 提高人胰岛素前体融合蛋白酶切转换成b30缺苏氨酸人胰岛素产率的方法 |
| EP2956003A2 (en) * | 2013-02-13 | 2015-12-23 | Laboratoire Français du Fractionnement et des Biotechnologies | Proteins with modified glycosylation and methods of production thereof |
| JP2016508515A (ja) | 2013-02-13 | 2016-03-22 | ラボラトワール フランセ デュ フラクショヌマン エ デ ビオテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ ｅｔ ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ | 高ガラクトシル化抗ＴＮＦ−α抗体およびその使用 |
| US10362771B2 (en) | 2014-11-20 | 2019-07-30 | Kyoto University | Method for knock-in of DNA into target region of mammalian genome, and cell |
| CN105219774B (zh) * | 2015-10-10 | 2019-04-30 | 广西大学 | 猪胰岛素特异性表达启动子pip2及其应用 |
| CN117327681B (zh) * | 2022-12-31 | 2024-06-18 | 义翘神州(泰州)科技有限公司 | 促进哺乳动物细胞表达蛋白正确折叠的分子伴侣质粒及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4654324A (en) * | 1981-08-27 | 1987-03-31 | Eli Lilly And Company | Human proinsulin pharmaceutical formulations |
| US5322775A (en) * | 1986-06-30 | 1994-06-21 | Pharmaceutical Proteins Ltd. | Peptide production |
| US5633076A (en) * | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| US5831141A (en) * | 1991-01-11 | 1998-11-03 | United States Of America As Represented By The Department Of Health And Human Services | Expression of a heterologous polypeptide in mammary tissue of transgenic non-human mammals using a long whey acidic protein promoter |
| US6011197A (en) * | 1997-03-06 | 2000-01-04 | Infigen, Inc. | Method of cloning bovines using reprogrammed non-embryonic bovine cells |
| CN1058972C (zh) * | 1997-08-15 | 2000-11-29 | 中国农业大学 | 用动物乳房生产人的生长激素 |
| US6451527B1 (en) * | 1997-08-29 | 2002-09-17 | Selective Genetics, Inc. | Methods using genetic package display for selecting internalizing ligands for gene delivery |
| US20030005468A1 (en) * | 1998-06-19 | 2003-01-02 | Meade Harry M. | Methods and vectors for improving nucleic acid expression |
| WO2000000625A1 (en) * | 1998-06-26 | 2000-01-06 | Ppl Therapeutics (Scotland) Limited | Methods for production of recombinant polypeptides |
| NZ518263A (en) * | 1999-10-14 | 2004-03-26 | Gtc Biotherapeutics Inc | Methods of producing a target molecule in a transgenic animal and purification of the target molecule |
| US7105314B2 (en) * | 2001-04-02 | 2006-09-12 | Novo Nordisk A/S | Method for making human insulin precursors |
| CN101413003A (zh) * | 2003-09-30 | 2009-04-22 | 斯特林贝尔德生物技术北美公司 | 在转基因哺乳动物的奶中生产外源蛋白的方法以及从其中纯化蛋白的方法 |
| EP1687421B1 (en) * | 2003-09-30 | 2018-06-27 | Sterrenbeld Biotechnologie North America, Inc. | A process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom |
-
2008
- 2008-06-13 JP JP2010512195A patent/JP2010528677A/ja not_active Withdrawn
- 2008-06-13 JP JP2010512197A patent/JP2010528678A/ja not_active Withdrawn
- 2008-06-13 CA CA2690564A patent/CA2690564A1/en not_active Abandoned
- 2008-06-13 RU RU2010100910/10A patent/RU2010100910A/ru unknown
- 2008-06-13 EP EP08768438A patent/EP2061895A1/en not_active Withdrawn
- 2008-06-13 RU RU2010100911/10A patent/RU2010100911A/ru unknown
- 2008-06-13 BR BRPI0811390-4A2A patent/BRPI0811390A2/pt not_active IP Right Cessation
- 2008-06-13 CN CN200880022856A patent/CN101755054A/zh active Pending
- 2008-06-13 WO PCT/US2008/007398 patent/WO2008156668A1/en active Application Filing
- 2008-06-13 WO PCT/US2008/007400 patent/WO2008156670A1/en active Application Filing
- 2008-06-13 AU AU2008266993A patent/AU2008266993A1/en not_active Abandoned
- 2008-06-13 EP EP08768440A patent/EP2061896A1/en not_active Withdrawn
- 2008-06-13 US US12/138,526 patent/US20090228999A1/en not_active Abandoned
- 2008-06-13 CA CA2690565A patent/CA2690565A1/en not_active Abandoned
- 2008-06-13 CN CN200880022998.8A patent/CN101802210A/zh active Pending
- 2008-06-13 MX MX2009013421A patent/MX2009013421A/es not_active Application Discontinuation
- 2008-06-13 US US12/138,529 patent/US20090187999A1/en not_active Abandoned
- 2008-06-13 AU AU2008266995A patent/AU2008266995A1/en not_active Abandoned
- 2008-06-13 MX MX2009013371A patent/MX2009013371A/es not_active Application Discontinuation
-
2010
- 2010-01-13 CO CO10002774A patent/CO6300794A2/es not_active Application Discontinuation
- 2010-01-13 CO CO10002779A patent/CO6300796A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0811390A2 (pt) | 2014-12-30 |
| CA2690565A1 (en) | 2008-12-24 |
| CN101802210A (zh) | 2010-08-11 |
| WO2008156668A1 (en) | 2008-12-24 |
| MX2009013421A (es) | 2010-03-22 |
| JP2010528677A (ja) | 2010-08-26 |
| EP2061895A1 (en) | 2009-05-27 |
| RU2010100911A (ru) | 2011-07-20 |
| US20090187999A1 (en) | 2009-07-23 |
| WO2008156670A1 (en) | 2008-12-24 |
| US20090228999A1 (en) | 2009-09-10 |
| MX2009013371A (es) | 2010-01-25 |
| AU2008266993A1 (en) | 2008-12-24 |
| RU2010100910A (ru) | 2011-07-20 |
| EP2061896A1 (en) | 2009-05-27 |
| JP2010528678A (ja) | 2010-08-26 |
| AU2008266995A1 (en) | 2008-12-24 |
| CO6300796A2 (es) | 2011-07-21 |
| CA2690564A1 (en) | 2008-12-24 |
| CN101755054A (zh) | 2010-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6300794A2 (es) | Mamiferos transgenicos que producen proteina exogena en la leche | |
| AR047721A1 (es) | Un proceso para producir proteina exogena en la leche de mamiferos transgenicos y un proceso para purificar proteinas a partir de ella | |
| BR112012007854A2 (pt) | metodos de produção de glicoproteínas em culturas de células de mamíferos usando glicocorticoides | |
| CO2019014704A2 (es) | Agentes potenciadores para la transfección celular mejorada y/o la producción del vector raav | |
| AR078010A1 (es) | Moleculas de acido nucleico regulatorias para aumentar la expresion genica constitutiva en las plantas | |
| AR091482A1 (es) | Celulas modificadas geneticamente y metodos par su obtencion | |
| CY1118970T1 (el) | Στελεχη shigella με υπερφλυκταινωση | |
| AR018038A1 (es) | Un procedimiento para producir un embrion animal, y los animales que se obtienen empleando este procedimiento | |
| DE502006007198D1 (de) | Verfahren zur herstellung von permanenten humanen zelllinien | |
| ATE393571T1 (de) | Aviäres expressionssystem für fremdproteine | |
| Schneider | Receptor-mediated mechanisms in ovarian follicle and oocyte development | |
| Skrzyszowska et al. | Generating cloned goats by somatic cell nuclear transfer—Molecular determinants and application to transgenics and biomedicine | |
| Yin et al. | Generation of cloned transgenic cats expressing red fluorescence protein | |
| UY33852A (es) | ?moléculas de ácido nucleico que se dirigen a la proteína de unión a gtp pequeña de rho1 y que confieren resistencia a las plagas de coleópteros?. | |
| PT1002080E (pt) | Proteinas fluorescentes como reporter especifico de tipo de celulas | |
| DE60037107D1 (de) | Pluripotente embryonale keimzellinie aus vögeln | |
| Zhu et al. | KLF4 facilitates chromatin accessibility remodeling in porcine early embryos | |
| CU23102A1 (es) | Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos | |
| RU2016140528A (ru) | Способы получения рекомбинантных гликопротеинов с модифицированным гликозилированием | |
| AR067333A1 (es) | Un proceso para la produccion de proteinas exogenas en la leche de mamiferos transgenicos y un proceso para purificar proteinas a partir de la misma | |
| AR102969A1 (es) | Métodos para producir polipéptidos modificados por ctp (péptido carboxilo terminal) de acción prolongada | |
| Singh et al. | Characterization of GSF289: a fibroblast cell line derived from goat ear skin explants | |
| AR046590A1 (es) | Promotor para la expresion de transgenes especificos para la epidermis de plantas | |
| AR067017A1 (es) | Un proceso para la obtencion de mamiferos transgenicos que produzcan proteinas exogenas en leche y los mamiferos obtenidos mediante dicho proceso | |
| He | Efficient generation of pLEG1a-/-and pLEG1b-/-double knockout minipig fibroblast cells using the CRISPR/Cas9 system. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |